TY  - GEN
AU  - Ditschkowski,M
AU  - Haferlach,C
AU  - Schulte,C
AU  - Trenschel,R
AU  - Beelen,D W
TI  - Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT
SN  - 1476-5365
PY  - 2009///1214
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Benzamides
KW  - Bone Marrow Transplantation
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - pathology
KW  - Leukemia, Myeloid, Acute
KW  - Male
KW  - Piperazines
KW  - Pyrimidines
N1  - Publication Type: Case Reports; Letter
UR  - https://doi.org/10.1038/bmt.2009.8
ER  -